» Articles » PMID: 3089553

Bone Remodeling During the Development of Osteoporosis in Paraplegia

Overview
Specialty Pathology
Date 1986 Jun 1
PMID 3089553
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoporosis developing during the first weeks after the onset of traumatic paraplegia was studied with cortical and cancellous samples of iliac crest and tibia of 14 patients, and compared to normals. We used a procedure of bone particle fractionation (according to degree of mineralization) that allowed us to establish a profile reflecting the metabolic remodeling of bone and to analyze the organic matrix of the newly synthesized tissue. In paraplegics, we observed a large increase in the proportion of little calcified bone in the cortical as well as in the cancellous bone. Based on amino acid analyses, we found a decreased number of hydroxyproline residues in the newly synthesized organic matrix from paraplegia bone resulting either from an alteration of the prolyl hydroxylation or from the presence of an excess of noncollagen polypeptides. These results, together with previously published data reporting increased urinary hydroxyproline and calcium kinetic parameters, suggest an enhanced rate of skeletal remodeling in acute paraplegia. When investigated 2 years after injury, the patterns of distribution approach that of normal subjects.

Citing Articles

Exoskeletal-assisted walking combined with transcutaneous spinal cord stimulation to improve bone health in persons with spinal cord injury: study protocol for a prospective randomised controlled trial.

Cirnigliaro C, Kuo W, Forrest G, Spungen A, Parrott J, Cardozo C BMJ Open. 2024; 14(9):e086062.

PMID: 39289024 PMC: 11409316. DOI: 10.1136/bmjopen-2024-086062.


Comparison of the prevalence of osteoporosis in people with spinal cord injury according to bone mineral density reference values for the diagnosis of osteoporosis: a retrospective, cross-sectional study.

Lim J, Kim O BMC Musculoskelet Disord. 2024; 25(1):95.

PMID: 38279100 PMC: 10811804. DOI: 10.1186/s12891-024-07184-9.


The Pathophysiology, Identification and Management of Fracture Risk, Sublesional Osteoporosis and Fracture among Adults with Spinal Cord Injury.

Craven B, Cirnigliaro C, Carbone L, Tsang P, Morse L J Pers Med. 2023; 13(6).

PMID: 37373955 PMC: 10300795. DOI: 10.3390/jpm13060966.


Polydatin administration attenuates the severe sublesional bone loss in mice with chronic spinal cord injury.

Zhan J, Luo D, Zhao B, Chen S, Luan J, Luo J Aging (Albany NY). 2022; 14(21):8856-8875.

PMID: 36378815 PMC: 9699758. DOI: 10.18632/aging.204382.


Suppression of cancer-associated bone loss through dynamic mechanical loading.

Pagnotti G, Thompson W, Guise T, Rubin C Bone. 2021; 150:115998.

PMID: 33971314 PMC: 10044486. DOI: 10.1016/j.bone.2021.115998.


References
1.
Bergmann P, Heilporn A, Schoutens A, Paternot J, Tricot A . Longitudinal study of calcium and bone metabolism in paraplegic patients. Paraplegia. 1977; 15(2):147-59. DOI: 10.1038/sc.1977.20. View

2.
CHANTRAINE A, van Ouwenaller C, Hachen H, Schinas P . Intra-medullary pressure and intra-osseous phlebography in paraplegia. Paraplegia. 1979; 17(4):391-9. DOI: 10.1038/sc.1979.75. View

3.
Whyte M, Bergfeld M, Murphy W, Avioli L, Teitelbaum S . Postmenopausal osteoporosis. A heterogeneous disorder as assessed by histomorphometric analysis of Iliac crest bone from untreated patients. Am J Med. 1982; 72(2):193-202. DOI: 10.1016/0002-9343(82)90810-5. View

4.
CHANTRAINE A, Heynen G, Franchimont P . Bone metabolism, parathyroid hormone, and calcitonin in paraplegia. Calcif Tissue Int. 1979; 27(3):199-204. DOI: 10.1007/BF02441186. View

5.
Nusgens B, CHANTRAINE A, Lapiere C . The protein in the matrix of bone. Clin Orthop Relat Res. 1972; 88:252-74. DOI: 10.1097/00003086-197210000-00038. View